The CEO of Eli Lilly is speaking out! Okay, not as forcefully as the previous sentence would imply. But it’s clear to see that the recent pledge by many private third parties to contribute a whopping infusion of almost $2 trillion in support over 10 years as part of the Obama healthcare delivery overhaul and cost reduction plan does have him concerned. Just a little.

“There’s been some who characterized that as a windfall. I don’t think that’s been proven to be the case. I do believe there would be some additional benefit if we could ensure the 45 to 47 million people (without insurance) had access to the kind of quality care that those of us with insurance take for granted,” [Lilly CEO John] Lechleiter said after delivering remarks to the U.S. Chamber of Commerce.

If you believed all of the media accounts surrounding this event over the past couple of days, you may be wondering why now, why Lilly and no one else … yet? After all, the pharma company’s CEO is saying, though in not so many words, that his industry really doesn’t desire a public health plan. If anything, that ol’ standby — tax credits — will equalize the playing field and keep government intrusion to a minimum, right?

There’s a nagging feeling that he may be the only critic on Obama’s planned reforms at this time.

Related Posts Within Doctor Pundit:

1. Obama Realizes Difficulties in Healthcare Policy Overhaul as He Prepares for Summit Now that Obama has made his HHS choice official and...
2. Regarding Obama’s Healthcare Funding Overhaul, Some Senators Leary Just how much of  an influence is the financial support...
3. Pharma Company Goes on the Defensive Amid New Avandia Attacks A safety review of GSK’s Avandia, under fire and intense...
4. Pharma Company’s Research Actions May Have Short Term Setback in Alzheimer Research Pharma company Eli Lilly recently scrapped further development of an...
5. Pharma Company Strives to Keep Star Performing Drug Close Twenty-eleven and 2012 are going to be remembered in the...